Biospring Partners
Biospring Partners is a growth equity firm, founded in 2020 and headquartered in New York City, that invests in growth-stage B2B companies across life sciences technology. The firm builds long-term partnerships with management teams and provides capital plus portfolio-level value creation support focused on scaling companies in sectors such as pharma services, biomanufacturing, cell & gene therapy, digital health, and life-sciences software.
Industries
Nr. of Employees
small (1-50)
Biospring Partners
50 W 57th St, New York, NY 10019 (Headquarters) — https://goo.gl/maps/N3mXE4K1qNWVJFCs6
Portfolio
Offers discovery, development and cGMP manufacturing for biologics, ADCs; facilities in Cambridge UK, San Diego (500L–2000L bioreactors) and Bristol, PA; >400 projects referenced.
#CDMO / Contract development and manufacturing services for biologics and ADCs
Provides discovery, development and manufacturing services for cell and gene therapies; expertise in iPSCs.
#Cell & Gene Therapy manufacturing / CGT aggregator
Builds infrastructure and software for accessible, affordable health testing programs used by enterprises and service organizations.
#Health testing platforms / Telehealth-enabled testing programs
Platform connecting researchers with suppliers to improve visibility and insight into life-science supply chains.
#Life-science procurement / e-commerce for reagents and instrumentation
AI-based pathology platform aimed at improving diagnosis for clinical trials; leadership includes Dr. Andrew Beck (CEO).
#Pathology AI / Diagnostics
Full-service clinical trial provider partnering with community clinics to enable access to trials (Dallas/Ft. Worth market referenced).
#Clinical research / Outsourced clinical trial site services
Offers discovery, development and cGMP manufacturing for biologics, ADCs; facilities in Cambridge UK, San Diego (500L–2000L bioreactors) and Bristol, PA; >400 projects referenced.
#CDMO / Contract development and manufacturing services for biologics and ADCs
Provides discovery, development and manufacturing services for cell and gene therapies; expertise in iPSCs.
#Cell & Gene Therapy manufacturing / CGT aggregator
Builds infrastructure and software for accessible, affordable health testing programs used by enterprises and service organizations.
#Health testing platforms / Telehealth-enabled testing programs
Platform connecting researchers with suppliers to improve visibility and insight into life-science supply chains.
#Life-science procurement / e-commerce for reagents and instrumentation
AI-based pathology platform aimed at improving diagnosis for clinical trials; leadership includes Dr. Andrew Beck (CEO).
#Pathology AI / Diagnostics
Full-service clinical trial provider partnering with community clinics to enable access to trials (Dallas/Ft. Worth market referenced).
#Clinical research / Outsourced clinical trial site services